Pharmaceutical composition to be used in treatment of acute myocardial ischaemia
PL411835A1
Set of oligonucleotide starters for determination of polymorphisms type SNP for CYP2C19*17(-3402C>T), CYP2C19*3, ABCB1(C3435C>T) and CYP2C19*2 genes and method for detection of disturbances in clopidogrel activity using the set of oligonucleotide starters
PL411495A1
Vessels for preparation of chromatographic samples
PL411405A1
Method for testing biological samples subjected to tension in the Raman spectroscope and the device for the tension of tested biological samples
PL410210A1
Eukaryotic expression vector encoding the human basic fibroblast growth factor, method for obtaining it and application
PL406839A1
Eukaryotic expression vector, coding human angiopoietin-1 and the human vascular endothelium growth factor, method for producing it and application
PL406259A1
Eucaryotic expressive vector coding human hepatocyte growth factor and the human vascular endothelium growth factor, method for producing it and application
PL405602A1
Device for photobiomodulation of blood during the extracorporal circulation
PL403654A1
Eukaryotic expression vector encoding the human angiopoietin 1, process for its preparation and the use
PL402099A1
Bipolar electrode for receiving neuromuscular biopotentials
PL398962A1
Endotracheal intubation tube with additional equipment
